JOURNAL ARTICLE
RESEARCH SUPPORT, NON-U.S. GOV'T
Add like
Add dislike
Add to saved papers

Evaluation of the fate of perfluoroalkyl compounds in wastewater treatment plants.

Water Research 2010 June
Recent studies have shown that the wastewater treatment plant (WWTP) is a significant source of perfluoroalkyl compounds (PFCs) in natural water. In this study, 10 PFCs were analyzed in influent and effluent wastewater and sludge samples in 15 municipal, 4 livestock and 3 industrial WWTPs in Korea. The observed distribution pattern of PFCs differed between the wastewater and sludge samples. Perfluorooctane sulfonate (PFOS) was dominant in the sludge samples with a concentration ranging from 3.3 to 54.1 ng/g, whereas perfluorooctanoic acid (PFOA) was dominant in wastewater and ranged from 2.3 to 615 ng/L and 3.4 to 591 ng/L in influent and effluent wastewater, respectively. Principal component analysis (PCA) results provided an explanation for this variation in PFC distribution patterns in the aqueous and sludge samples. The fates of PFCs in the WWTPs were related with the functional groups. The PFOS concentrations tended to decrease after treatment in most WWTPs, whereas PFOA increased. The different fates of PFOA and PFOS in WWTPs were attributed to the higher organic carbon-normalized distribution coefficient of perfluoroalkylsulfonate (PFASs) than that of the carboxylate analog, indicating the preference of PFASs to partition to sludge. Although industrial WWTPs contained high concentration of PFCs, they are not the main source of PFCs in Korean water environment because of their small release amount. WWTPs located in big cities discharged more PFCs, suggesting household sewage is one of the significant sources of PFCs contamination in the environment.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app